Deutsche Bank Ag\ Leap Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$1.39 - $3.07 $172,829 - $381,717	-124,338 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $7.94 $74,880 - $309,660	39,000 Added 45.7%	124,338 $248,000
Q3 2018 Nov 14, 2018	BUY	$6.52 - $9.13 $36,512 - $51,128	5,600 Added 7.02%	85,338 $664,000
Q2 2018 Aug 14, 2018	BUY	$6.76 - $10.01 $73,122 - $108,278	10,817 Added 15.69%	79,738 $717,000
Q1 2018 May 15, 2018	BUY	$6.06 - $8.54 $376,453 - $530,513	62,121 Added 913.54%	68,921 $572,000
Q4 2017 Feb 14, 2018	BUY	$4.99 - $7.3 $33,932 - $49,640	6,800	6,800 $42,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $254M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.